Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery

Inclusion Criteria

• •Provide written informed consent, approved by the appropriate ethics committee;
• •Able to comply with the study requirements and visit schedule;
• •At least 18 years of age of either sex or any race;
• •Will undergo unilateral cataract extraction via phacoemulsification and PCIOL implantation in the study eye;
• •Have an anterior chamber cell score ≥ 2 at Visit 2 (Day 1 \[18 to 30 hours post- uncomplicated cataract surgery without vitreous loss\]);